Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
This report aims to provide a comprehensive presentation of the global market for Bioengineered Skin Substitutes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioengineered Skin Substitutes. This report contains market size and forecasts of Bioengineered Skin Substitutes in global, including the following market information:
Global Bioengineered Skin Substitutes Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Bioengineered Skin Substitutes market was valued at US$ 1507.6 million in 2022 and is projected to reach US$ 3190.3 million by 2029, at a CAGR of 11.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global important companies in bioengineered skin substitutes includes Allergan (AbbVie), AlloSource, Organogenesis, and BD. The head company shares over 30% of the market. Geographically speaking, Americas holds about 50% of global market share, followed by Europe with about 35% share. Bioengineered skin substitutes includes Allogeneic Acellular, Xenogeneic, Allogeneic Cells, and Autologous. Allogeneic Acellular is the largest part of bioengineered skin substitutes industry, has a share about 80%. Other key parts include Xenogeneic who shares nearly 15% , and Autologous who shares about 5%. The application of bioengineered skin substitutes includes hospitals,specialty clinics and wound care centers. Hospitals shares the largest percent of 60.30%.
We surveyed the Bioengineered Skin Substitutes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioengineered Skin Substitutes Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, by Type, 2022 (%)
- Allogeneic Acellular
- Xenogeneic
- Allogeneic Cells
- Autologous
Global Bioengineered Skin Substitutes Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Specialty Clinics
- Wound Care Centers
Global Bioengineered Skin Substitutes Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bioengineered Skin Substitutes Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bioengineered Skin Substitutes revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bioengineered Skin Substitutes revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Allergan (AbbVie)
- AlloSource
- Organogenesis
- BD
- Smith & Nephew
- Integra LifeSciences
- Synthes (Johnson & Johnson)
- Axogen
- Vericel Corporation
- LifeNet Health
- MTF Biologics
- Arthrex
- Wright Medical Group NV (Stryker)
- Cook Biotech Incorporated
- Aroa Biosurgery
- Surgalign Holdings
- Anika Therapeutics
- Forticell Bioscience
- MLM Biologics
- Promethean LifeSciences
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Bioengineered Skin Substitutes, market overview.
- Chapter 2: Global Bioengineered Skin Substitutes market size in revenue.
- Chapter 3: Detailed analysis of Bioengineered Skin Substitutes company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Bioengineered Skin Substitutes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
